First Time Loading...

Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603

Watchlist Manager
Shijiazhuang Yiling Pharmaceutical Co Ltd Logo
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Watchlist
Price: 19.84 CNY -0.55% Market Closed
Updated: May 16, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Shijiazhuang Yiling Pharmaceutical Co Ltd

Wall Street analysts forecast Shijiazhuang Yiling Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shijiazhuang Yiling Pharmaceutical Co Ltd is 25.82 CNY with a low forecast of 17.17 CNY and a high forecast of 34.39 CNY.

Lowest Forecast
Wall Street Target
17.17 CNY
13% Downside
Average Forecast
Wall Street Target
25.82 CNY
30% Upside
Highest Forecast
Wall Street Target
34.39 CNY
73% Upside
Lowest
Price Target
17.17 CNY
13% Downside
Average
Price Target
25.82 CNY
30% Upside
Highest
Price Target
34.39 CNY
73% Upside
Shijiazhuang Yiling Pharmaceutical Co Ltd Competitors:
Price Targets
SEQUENT
SeQuent Scientific Ltd
12% Upside
b
BTMD
biote Corp
51% Upside
000423
Dong-E-E-Jiao Co Ltd
1% Upside
4554
Fuji Pharma Co Ltd
33% Upside
SEQUENT
SeQuent Scientific Ltd
12% Upside
b
BTMD
biote Corp
51% Upside
000423
Dong-E-E-Jiao Co Ltd
1% Upside
4554
Fuji Pharma Co Ltd
33% Upside
GSK
GlaxoSmithKline PLC
7% Upside
ETON
Eton Pharmaceuticals Inc
152% Upside
ORMP
Oramed Pharmaceuticals Inc
81% Upside
NOVN
Novartis AG
8% Upside

Revenue
Forecast

Revenue Estimate
Shijiazhuang Yiling Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Shijiazhuang Yiling Pharmaceutical Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 13%.

16%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Shijiazhuang Yiling Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Shijiazhuang Yiling Pharmaceutical Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 17%.

17%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Shijiazhuang Yiling Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Shijiazhuang Yiling Pharmaceutical Co Ltd's net income is 15%. The projected CAGR for the next 3 years is 17%.

15%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-10%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shijiazhuang Yiling Pharmaceutical Co Ltd's stock price target?
Price Target
25.82 CNY

According to Wall Street analysts, the average 1-year price target for Shijiazhuang Yiling Pharmaceutical Co Ltd is 25.82 CNY with a low forecast of 17.17 CNY and a high forecast of 34.39 CNY.

What is Shijiazhuang Yiling Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Shijiazhuang Yiling Pharmaceutical Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 13%.

What is Shijiazhuang Yiling Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Shijiazhuang Yiling Pharmaceutical Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 17%.

What is Shijiazhuang Yiling Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Shijiazhuang Yiling Pharmaceutical Co Ltd's net income is 15%. The projected CAGR for the next 3 years is 17%.

ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.